Novavax (NVAX) Reports Q4 Loss, Tops Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of$ 0.75. This compares to loss of $1.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 32%. A quarter ago, it was expected that this vaccine maker would post a loss of$ 0.87 per share when it actually produced a loss of $0.76, delivering a surprise of 12.64%.Over the last four quarters, the company has surpassed con ...